Evidence map›Paper›PMID 33811859›Full record

ArticleThe Journal of biological chemistry

Disruption of the cholinergic anti-inflammatory response by R5-tropic HIV-1 protein gp120

Sonnieliz Cotto Ríos, José O Colón Sáez, Orestes Quesada, Katherine Quiroz Figueroa, José A Lasalde Dominicci

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Cholinergic Polarization of Human Macrophages.International journal of molecular sciences · 2023
    Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sonnieliz Cotto RíosDepartment of Chemistry, University of Puerto Rico, Río Piedras Campus, San Juan, Puerto Rico, USA.
José O Colón SáezDepartment of Pharmaceutical Sciences, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico, USA.
Orestes QuesadaDepartment of Physical Sciences, University of Puerto Rico, Río Piedras Campus, San Juan, Puerto Rico, USA.
Katherine Quiroz FigueroaDepartment of Biology, University of Puerto Rico, Río Piedras Campus, San Juan, Puerto Rico, USA.
José A Lasalde DominicciDepartment of Chemistry, University of Puerto Rico, Río Piedras Campus, San Juan, Puerto Rico, USA; Department of Biology, University of Puerto Rico, Río Piedras Campus, San Juan, Puerto Rico, USA; Institute of Neurobiology, University of Puerto Rico Medical Science Campus, San Juan, Puerto Rico, USA; Molecular Sciences Research Center, University of Puerto Rico, San Juan, Puerto Rico, USA. Electronic address: jose.lasalde@upr.edu.
University of Puerto Rico at Río Piedras · PRUniversity of Puerto Rico, Medical Sciences Campus · PR

Funding

Therapeutic CoreP30MH075673 · NIMH · JOHNS HOPKINS UNIVERSITY · PI Barbara Stauch Slusher · 2006 to 2026
$33.2M
Upgrade Laboratories Facilities at UPR-Rio PiedrasR25GM061151 · NIGMS · UNIVERSITY OF PUERTO RICO RIO PIEDRAS · PI CARBALLEIRA, NESTOR MANUEL · 2001 to 2023
$32.5M
TECHNOLOGIES AND RESOURCES FOR CORE LABORATORIESU54MD007587 · NIMHD · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI BENABE, JULIO E, LUCIANO, CARLOS A. · 2012 to 2018
$23.2M
The Role of Sensory Input to Mammalian Locomotion After the Loss of supraspinal.P20GM103642 · NIGMS · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI LASALDE-DOMINICCI, JOSE ANTONIO · 2013 to 2023
$20.6M
Tracking and Evaluation CoreU54GM133807 · NIGMS · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI ACOSTA-PEREZ, EDNA · 2020 to 2024
$17.7M
TRANSLATIONAL PROTEOMICS CENTERG12MD007600 · NIMHD · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI FERNANDEZ-REPOLLET, EMMA · 2012 to 2016
$11.0M
TRCLU54RR026139 · NCRR · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI ZORRILLA, CARMEN D · 2010 to 2011
$8.4M
NCRR NIH HHS U54 RR026139NIGMS NIH HHS P20 GM103642NIGMS NIH HHS R25 GM061151NIGMS NIH HHS U54 GM133807NIMHD NIH HHS G12 MD007600NIMHD NIH HHS U54 MD007587NIMH NIH HHS P30 MH075673
6 · The paper itself

Abstract

Despite current pharmacological intervention strategies, patients with HIV still suffer from chronic inflammation. The nicotinic acetylcholine receptors (nAChRs) are widely distributed throughout the nervous and immune systems. In macrophages, activation of alpha7-nAChR (α7-nAChR) controls inflammatory processes through the cholinergic anti-inflammatory response (CAR). Given that this innate immune response controls inflammation and α7-nAChR plays a critical role in the regulation of systemic inflammation, we investigated the effects of an R5-tropic HIV soluble component, gp120

Indexed as

alpha7 Nicotinic Acetylcholine ReceptorCytokinesHIV-1HIV Envelope Protein gp120HIV InfectionsHumansInflammationMacrophagesMonocytesReceptors, CCR5alpha7 Nicotinic Acetylcholine ReceptorCytokinesgp120 protein, Human immunodeficiency virus 1HIV Envelope Protein gp120Receptors, CCR5cholinergic anti-inflammatory response (CAR)glycoproteingp120(JRFL)human immunodeficiency virus type 1 (HIV-1)inflammationnicotinic acetylcholine receptor (nAChR)

Identifiers

PMID33811859
PMCPMC8102909
OpenAlexW3149995846

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.